Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.85B |
| 2 |
Tesla
TSLA
|
+$1.78B |
| 3 |
Apple
AAPL
|
+$1.57B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.49B |
| 5 |
Mastercard
MA
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.3B |
| 2 |
Phillips 66
PSX
|
+$650M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$475M |
| 4 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$432M |
| 5 |
NRG Energy
NRG
|
+$387M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.59% |
| 2 | Financials | 9.21% |
| 3 | Consumer Discretionary | 7.33% |
| 4 | Healthcare | 5.59% |
| 5 | Communication Services | 5.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
New York Times
NYT
$10.3B
| $10M | ﹤0.01% |
201,945
-49,231
| -20% | -$2.47M |
|
1402
KB Home
KBH
$3.54B
| $10M | ﹤0.01% |
172,096
-84,934
| -33% | -$5.41M |
|
1403
Invesco NASDAQ 100 ETF
QQQM
$102B
| $9.98M | ﹤0.01% |
51,718
+16,060
| +45% | +$3.36M |
|
1404
TG Therapeutics
TGTX
$7.64B
| $9.98M | ﹤0.01% |
253,094
-64,469
| -20% | -$2.17M |
|
1405
PVH
PVH
$3.91B
| $9.97M | ﹤0.01% |
154,165
+75,030
| +95% | +$6.06M |
|
|
CWAN
1406
DELISTED
Clearwater Analytics
CWAN
| $9.96M | ﹤0.01% |
371,678
-22,182
| -6% | -$623K |
|
1407
PUT
Rockwell Automation
ROK
$49.7B
| $9.95M | ﹤0.01% |
+38,500
| New | +$10.7M |
|
|
PRMB
1408
Primo Brands
PRMB
$8.56B
| $9.93M | ﹤0.01% |
279,862
-561,928
| -67% | -$18.4M |
|
1409
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.28B
| $9.92M | ﹤0.01% |
339,388
-50,513
| -13% | -$1.43M |
|
1410
Service Corp International
SCI
$11.4B
| $9.89M | ﹤0.01% |
123,318
-30,253
| -20% | -$2.38M |
|
1411
Icon
ICLR
$12.8B
| $9.88M | ﹤0.01% |
56,474
-3,254
| -5% | -$631K |
|
1412
Home BancShares
HOMB
$6.22B
| $9.88M | ﹤0.01% |
349,459
-161,087
| -32% | -$4.71M |
|
1413
FMC
FMC
$1.3B
| $9.88M | ﹤0.01% |
234,130
-98,953
| -30% | -$4.4M |
|
1414
Tanger
SKT
$4.43B
| $9.85M | ﹤0.01% |
291,621
-36,478
| -11% | -$1.22M |
|
1415
Tandem Diabetes Care
TNDM
$1.63B
| $9.85M | ﹤0.01% |
514,006
+37,032
| +8% | +$1.08M |
|
1416
Revolution Medicines
RVMD
$44.1B
| $9.85M | ﹤0.01% |
278,451
-130,163
| -32% | -$5.28M |
|
1417
Watts Water Technologies
WTS
$12.8B
| $9.81M | ﹤0.01% |
48,130
-20,618
| -30% | -$4.32M |
|
1418
PUT
Live Nation Entertainment
LYV
$42.7B
| $9.79M | ﹤0.01% |
+75,000
| New | +$10.2M |
|
1419
First Horizon
FHN
$12B
| $9.79M | ﹤0.01% |
504,127
-747,200
| -60% | -$15.4M |
|
1420
SoFi Technologies
SOFI
$23.2B
| $9.78M | ﹤0.01% |
840,637
-241,852
| -22% | -$3.49M |
|
1421
Trupanion
TRUP
$1.34B
| $9.76M | ﹤0.01% |
261,824
+161,566
| +161% | +$6.72M |
|
1422
BHP
BHP
$229B
| $9.75M | ﹤0.01% |
200,843
+12,478
| +7% | +$621K |
|
1423
SL Green Realty
SLG
$3.95B
| $9.7M | ﹤0.01% |
168,176
+42,698
| +34% | +$2.69M |
|
1424
Rexford Industrial Realty
REXR
$8.07B
| $9.7M | ﹤0.01% |
247,791
-33,161
| -12% | -$1.33M |
|
1425
Tenet Healthcare
THC
$20.9B
| $9.68M | ﹤0.01% |
71,951
-136,782
| -66% | -$18M |
|
Similar funds
Barclays's Q1 2025 Portfolio in Review
As of Q1 2025, Barclays held 5,710 positions worth $353B, down 1.2% from $357B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $16.5B of net new capital in Q1 2025, opening 439 new positions and adding to 1,449 existing holdings. Its largest new stake was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.3B trimmed.
- Barclays's largest Q1 2025 buy was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $3.85B increase.
- Barclays's biggest Q1 2025 reduction was Honeywell, cutting an estimated $1.3B.
- Barclays fully exited Smartsheet Inc. in Q1 2025, selling an estimated $45.7M.
- Barclays's ten largest holdings make up 37% of its $353B portfolio in Q1 2025.
- Barclays opened 439 new positions and closed 470 in Q1 2025.
- Barclays's portfolio value fell 1.2% quarter-over-quarter to $353B.
Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.